SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Forward Pharma A/S (FWPAY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 52/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — FWPAY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-77.41
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-981.32 |
$0.00 |
$-22.48M |
- |
| 2013 |
$-685.21 |
$0.00 |
$-15.7M |
- |
| 2014 |
$-1,102.70 |
$0.00 |
$-19.02M |
- |
| 2015 |
$-275.32 |
$0.00 |
$-37M |
- |
| 2016 |
$-246.64 |
$0.00 |
$-33.34M |
- |
| 2017 |
$9,199.99 |
$1.25B |
$917.09M |
73.4% |
| 2018 |
$-368.51 |
$0.00 |
$-8.72M |
- |
| 2019 |
$-177.58 |
$0.00 |
$-4.22M |
- |
| 2020 |
$-268.72 |
$0.00 |
$-6.45M |
- |
| 2021 |
$-77.41 |
$0.00 |
$-1.89M |
- |
